1. Merck & Company, Inc. Merck announces voluntary worldwide withdrawal of VIOXX®. Available at: http://www.vioxx.com/vioxx/documents/english/vioxx_press_release.pdf. Accessed May 12, 2005.
2. National Institutes of Health. NIH halts use of COX-2 inhibitor in large cancer prevention trial. Available at: http://www.nih.gov/news/pr/dec2004/od-17.htm. Accessed May 12, 2005.
3. Parecoxib, valdecoxib, and cardiovascular risk;Furberg;Circulation,2005
4. Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis;Juni;Lancet,2004
5. European Medicines Agency. European Medicines Agency announces regulatory action on COX-2 inhibitors. Available at: http://www.emea.eu.int/htms/hotpress/d6275705.htm. Accessed May 12, 2005.